Daxor Management
Management criteria checks 3/4
Daxor's CEO is Michael Feldschuh, appointed in Sep 2016, has a tenure of 8.17 years. directly owns 3.36% of the company’s shares, worth €1.38M. The average tenure of the management team and the board of directors is 6 years and 6.1 years respectively.
Key information
Michael Feldschuh
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 8.2yrs |
| CEO ownership | 3.4% |
| Management average tenure | 6yrs |
| Board average tenure | 6.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$2m |
| Mar 31 2024 | n/a | n/a | US$984k |
| Dec 31 2023 | n/a | n/a | US$281k |
| Sep 30 2023 | n/a | n/a | US$2m |
| Jun 30 2023 | n/a | n/a | US$4m |
| Mar 31 2023 | n/a | n/a | US$5m |
| Dec 31 2022 | US$100k | US$100k | US$5m |
| Sep 30 2022 | n/a | n/a | US$5m |
| Jun 30 2022 | n/a | n/a | US$4m |
| Mar 31 2022 | n/a | n/a | US$5m |
| Dec 31 2021 | US$100k | US$100k | US$5m |
| Sep 30 2021 | n/a | n/a | US$3m |
| Jun 30 2021 | n/a | n/a | US$294k |
| Mar 31 2021 | n/a | n/a | -US$706k |
| Dec 31 2020 | US$100k | US$100k | -US$2m |
| Sep 30 2020 | n/a | n/a | -US$3m |
| Jun 30 2020 | n/a | n/a | -US$4m |
| Mar 31 2020 | n/a | n/a | -US$2m |
| Dec 31 2019 | US$100k | US$100k | -US$496k |
| Sep 30 2019 | n/a | n/a | -US$149k |
| Jun 30 2019 | n/a | n/a | US$197k |
| Mar 31 2019 | n/a | n/a | -US$344k |
| Dec 31 2018 | US$100k | US$100k | -US$886k |
| Sep 30 2018 | n/a | n/a | -US$1m |
| Jun 30 2018 | n/a | n/a | -US$1m |
| Mar 31 2018 | n/a | n/a | -US$1m |
| Dec 31 2017 | US$100k | US$100k | -US$1m |
Compensation vs Market: Insufficient data to establish whether Michael's total compensation is reasonable compared to companies of similar size in the German market.
Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.
CEO
Michael Feldschuh (55 yo)
8.2yrs
Tenure
US$100,000
Compensation
Mr. Michael Richard Feldschuh has been the Chief Executive Officer and President of Daxor Corp. since September 21, 2016. Mr. Feldschuh served as Acting Chief Executive Officer and President of Daxor Corp....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Scientific Officer & Director | no data | US$127.92k | 0.081% € 33.2k | |
| Chairman | 8.2yrs | US$100.00k | 3.36% € 1.4m | |
| CFO, Chief Compliance Officer & Corporate Secretary | 6.2yrs | no data | 0.23% € 95.9k | |
| Vice President of Development & Operations | 1.8yrs | no data | no data | |
| Senior VP of Marketing & Commercial Development | 6.4yrs | no data | no data | |
| Vice President of Sales | 5.8yrs | no data | no data | |
| Senior Vice President Commercialization & Customer Experience | no data | no data | no data | |
| Chief Medical Officer | less than a year | no data | no data |
6.0yrs
Average Tenure
59yo
Average Age
Experienced Management: DX5's management team is seasoned and experienced (6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Scientific Officer & Director | 7.8yrs | US$127.92k | 0.081% € 33.2k | |
| Chairman | 11.8yrs | US$100.00k | 3.36% € 1.4m | |
| Chairman of Medical Advisory Board | no data | no data | no data | |
| Independent Director | 2.8yrs | US$1.75k | 0.065% € 26.8k | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Independent Director | 8.8yrs | US$2.13k | 0.021% € 8.5k | |
| Independent Director | 4.4yrs | US$1.13k | 0% € 0 | |
| Independent Director | 4.4yrs | US$2.13k | 0.0062% € 2.5k |
6.1yrs
Average Tenure
66yo
Average Age
Experienced Board: DX5's board of directors are considered experienced (6.1 years average tenure).